Medication leaflets

Active substance

Results for the substance imipenem+cilastatin+relebactam

1 result

About this active substance

The combination of imipenem, cilastatin, and relebactam is an antibiotic used to treat complicated bacterial infections, including intra-abdominal infections, urinary tract infections, and hospital-acquired pneumonia. Relebactam is a beta-lactamase inhibitor that protects imipenem from enzymatic degradation, enhancing its effectiveness.

The medication is administered via intravenous injection under the supervision of a specialist.

Side effects may include nausea, diarrhea, headache, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or seizures may occur.

Patients should inform their doctor about any allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.